# QURA, Inc.

> QURA, Inc. is a preclinical medical-technology company in Massachusetts building a tiny implanted sensor that continuously measures blood pressure and wirelessly transmits medical-grade waveform data to patients and physicians in real time. Its QSmart platform - a vitamin-sized QSense implant paired with software and analytics - aims to replace the occasional cuff reading with always-on monitoring, targeting hypertension, the leading cardiovascular risk factor worldwide. The technology grew out of an earlier wireless implantable pressure sensor developed for glaucoma (intraocular pressure) monitoring.

- **Founded:** 2013
- **Headquarters:** Duxbury / Boston, Massachusetts, United States
- **Founders:** William G. Hendren, MD (Co-founder & Chief Executive Officer), Douglas Adams (Co-founder & President), David F. Hendren (Chief Business Officer)
- **Team size:** Approximately 4 employees
- **Products:** QSmart Platform, QSense, QSmart Wireless IOP Measurement Platform
- **Notable:** Developed a vitamin/AAA-battery-sized wireless implantable pressure sensor capable of continuous, medical-grade waveform monitoring., Raised a Series A led by InFocus Capital Partners and a $1M strategic investment from Santen Ventures (2018)., Adapted its wireless implantable pressure-sensor platform from glaucoma (intraocular pressure) to hypertension (blood pressure).

## Products & services

- **QSmart Platform** — An integrated platform combining a small implantable sensor device, software, and data analytics for managing hypertension and other chronic diseases.
- **QSense** — A tiny, implanted sensor placed beneath the skin in an outpatient or office setting that automatically collects continuous, medical-grade blood-pressure waveform data and transmits it wirelessly in real time.
- **QSmart Wireless IOP Measurement Platform** — An earlier application of the wireless implantable pressure sensor for continuous intraocular pressure (IOP) monitoring in glaucoma management.

## Achievements

- Developed a vitamin/AAA-battery-sized wireless implantable pressure sensor capable of continuous, medical-grade waveform monitoring.
- Raised a Series A led by InFocus Capital Partners and a $1M strategic investment from Santen Ventures (2018).
- Adapted its wireless implantable pressure-sensor platform from glaucoma (intraocular pressure) to hypertension (blood pressure).
- Member of the StartUp Health community since 2016.

## Latest updates

- **2024-02** — Dr. Will Hendren featured on the StartUp Health NOW podcast discussing how QURA's tiny implantables could change hypertension treatment.
- **2018-07** — Received $1M strategic investment from Santen Ventures for the QSmart wireless IOP platform.
- **2018-01** — InFocus Capital Partners completed a Series A investment in QURA.

## Links

- Website: https://qura-med.com
- LinkedIn: https://www.linkedin.com/company/qura-inc

---

Profile page: https://yespress.io/qura-inc
Published by YesPress — https://yespress.io
Last updated: 2026-06-13